nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—Microtubule Inhibition—Paclitaxel—kidney cancer	0.24	1	CiPCiCtD
Docetaxel—Paclitaxel—kidney cancer	0.225	1	CrCtD
Docetaxel—Cabazitaxel—Paclitaxel—kidney cancer	0.129	1	CrCrCtD
Docetaxel—melanoma—kidney cancer	0.0574	0.39	CtDrD
Docetaxel—pancreatic cancer—kidney cancer	0.0498	0.338	CtDrD
Docetaxel—lung cancer—kidney cancer	0.0402	0.273	CtDrD
Docetaxel—ABCB1—kidney cancer	0.0138	1	CbGaD
Docetaxel—MAP4—Paclitaxel—kidney cancer	0.0114	0.0661	CbGbCtD
Docetaxel—MAP2—Paclitaxel—kidney cancer	0.00823	0.0478	CbGbCtD
Docetaxel—MAPT—Paclitaxel—kidney cancer	0.00823	0.0478	CbGbCtD
Docetaxel—BCL2—Paclitaxel—kidney cancer	0.00654	0.038	CbGbCtD
Docetaxel—EGFR—Erlotinib—kidney cancer	0.0041	0.0238	CbGbCtD
Docetaxel—TUBB2A—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—TUBB8—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—TUBB4A—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—TUBB2B—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—TUBB3—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—TUBB6—Paclitaxel—kidney cancer	0.00376	0.0218	CbGbCtD
Docetaxel—NR1I2—Erlotinib—kidney cancer	0.00373	0.0217	CbGbCtD
Docetaxel—NR1I2—Paclitaxel—kidney cancer	0.00342	0.0198	CbGbCtD
Docetaxel—TUBB2A—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB4A—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB3—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB8—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB6—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB2B—Vinblastine—kidney cancer	0.00329	0.0191	CbGbCtD
Docetaxel—TUBB8—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB6—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB4A—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB2B—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB3—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB2A—Vincristine—kidney cancer	0.00324	0.0188	CbGbCtD
Docetaxel—TUBB1—Paclitaxel—kidney cancer	0.00314	0.0182	CbGbCtD
Docetaxel—TUBB—Paclitaxel—kidney cancer	0.00314	0.0182	CbGbCtD
Docetaxel—TUBB4B—Paclitaxel—kidney cancer	0.00314	0.0182	CbGbCtD
Docetaxel—TUBB4B—Vinblastine—kidney cancer	0.00276	0.016	CbGbCtD
Docetaxel—TUBB1—Vinblastine—kidney cancer	0.00276	0.016	CbGbCtD
Docetaxel—TUBB—Vinblastine—kidney cancer	0.00276	0.016	CbGbCtD
Docetaxel—TUBB—Vincristine—kidney cancer	0.00271	0.0157	CbGbCtD
Docetaxel—TUBB1—Vincristine—kidney cancer	0.00271	0.0157	CbGbCtD
Docetaxel—TUBB4B—Vincristine—kidney cancer	0.00271	0.0157	CbGbCtD
Docetaxel—ABCC10—Gemcitabine—kidney cancer	0.00266	0.0154	CbGbCtD
Docetaxel—ABCC10—Paclitaxel—kidney cancer	0.0024	0.0139	CbGbCtD
Docetaxel—ABCC10—Vincristine—kidney cancer	0.00207	0.012	CbGbCtD
Docetaxel—CYP1B1—Erlotinib—kidney cancer	0.00143	0.00827	CbGbCtD
Docetaxel—SLCO1B3—Paclitaxel—kidney cancer	0.00134	0.00778	CbGbCtD
Docetaxel—CYP3A7—Temsirolimus—kidney cancer	0.00133	0.00775	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.00133	0.00775	CbGbCtD
Docetaxel—CYP1B1—Paclitaxel—kidney cancer	0.0013	0.00757	CbGbCtD
Docetaxel—ABCC1—Dactinomycin—kidney cancer	0.0013	0.00753	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—kidney cancer	0.00129	0.00751	CbGbCtD
Docetaxel—CYP3A5—Temsirolimus—kidney cancer	0.001	0.00581	CbGbCtD
Docetaxel—ABCG2—Pazopanib—kidney cancer	0.000949	0.00551	CbGbCtD
Docetaxel—ABCC1—Paclitaxel—kidney cancer	0.000927	0.00538	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—kidney cancer	0.000868	0.00504	CbGbCtD
Docetaxel—ABCC1—Vinblastine—kidney cancer	0.000813	0.00472	CbGbCtD
Docetaxel—ABCC1—Vincristine—kidney cancer	0.000799	0.00464	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—kidney cancer	0.000703	0.00408	CbGbCtD
Docetaxel—ABCC2—Paclitaxel—kidney cancer	0.000686	0.00398	CbGbCtD
Docetaxel—ABCG2—Erlotinib—kidney cancer	0.000677	0.00393	CbGbCtD
Docetaxel—ABCB1—Temsirolimus—kidney cancer	0.000652	0.00378	CbGbCtD
Docetaxel—ABCG2—Paclitaxel—kidney cancer	0.00062	0.0036	CbGbCtD
Docetaxel—ABCC2—Sorafenib—kidney cancer	0.000609	0.00354	CbGbCtD
Docetaxel—ABCC2—Vinblastine—kidney cancer	0.000602	0.00349	CbGbCtD
Docetaxel—ABCC2—Vincristine—kidney cancer	0.000591	0.00343	CbGbCtD
Docetaxel—CYP3A4—Everolimus—kidney cancer	0.000578	0.00336	CbGbCtD
Docetaxel—ABCG2—Sorafenib—kidney cancer	0.000551	0.0032	CbGbCtD
Docetaxel—ABCG2—Vincristine—kidney cancer	0.000535	0.0031	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—kidney cancer	0.000499	0.0029	CbGbCtD
Docetaxel—ABCC2—Sunitinib—kidney cancer	0.000494	0.00287	CbGbCtD
Docetaxel—CYP3A7—Paclitaxel—kidney cancer	0.000458	0.00266	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.000458	0.00266	CbGbCtD
Docetaxel—ABCG2—Sunitinib—kidney cancer	0.000446	0.00259	CbGbCtD
Docetaxel—CYP3A7—Sorafenib—kidney cancer	0.000407	0.00236	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.000407	0.00236	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.000395	0.00229	CbGbCtD
Docetaxel—CYP3A7—Vincristine—kidney cancer	0.000395	0.00229	CbGbCtD
Docetaxel—CYP3A4—Temsirolimus—kidney cancer	0.00039	0.00227	CbGbCtD
Docetaxel—CYP3A5—Erlotinib—kidney cancer	0.000375	0.00218	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—kidney cancer	0.00037	0.00215	CbGbCtD
Docetaxel—CYP3A5—Paclitaxel—kidney cancer	0.000344	0.00199	CbGbCtD
Docetaxel—ABCB1—Pazopanib—kidney cancer	0.000342	0.00199	CbGbCtD
Docetaxel—MAPT—nephron tubule—kidney cancer	0.000337	0.0372	CbGeAlD
Docetaxel—ABCG2—Doxorubicin—kidney cancer	0.000334	0.00194	CbGbCtD
Docetaxel—CYP3A7—Sunitinib—kidney cancer	0.00033	0.00191	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00033	0.00191	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—kidney cancer	0.000313	0.00182	CbGbCtD
Docetaxel—CYP3A5—Sorafenib—kidney cancer	0.000305	0.00177	CbGbCtD
Docetaxel—CYP3A5—Vincristine—kidney cancer	0.000296	0.00172	CbGbCtD
Docetaxel—MAPT—cortex of kidney—kidney cancer	0.000289	0.0318	CbGeAlD
Docetaxel—ABCB1—Gemcitabine—kidney cancer	0.000248	0.00144	CbGbCtD
Docetaxel—CYP3A5—Sunitinib—kidney cancer	0.000247	0.00144	CbGbCtD
Docetaxel—ABCB1—Erlotinib—kidney cancer	0.000244	0.00142	CbGbCtD
Docetaxel—MAP4—renal system—kidney cancer	0.000241	0.0266	CbGeAlD
Docetaxel—MAP4—kidney—kidney cancer	0.000233	0.0257	CbGeAlD
Docetaxel—MAP4—cortex of kidney—kidney cancer	0.000227	0.025	CbGeAlD
Docetaxel—ABCB1—Paclitaxel—kidney cancer	0.000224	0.0013	CbGbCtD
Docetaxel—BCL2—renal system—kidney cancer	0.000219	0.0241	CbGeAlD
Docetaxel—MAP4—gonad—kidney cancer	0.000216	0.0238	CbGeAlD
Docetaxel—BCL2—kidney—kidney cancer	0.000212	0.0233	CbGeAlD
Docetaxel—CYP3A4—Pazopanib—kidney cancer	0.000205	0.00119	CbGbCtD
Docetaxel—ABCB1—Sorafenib—kidney cancer	0.000199	0.00115	CbGbCtD
Docetaxel—BCL2—gonad—kidney cancer	0.000196	0.0217	CbGeAlD
Docetaxel—ABCB1—Vinblastine—kidney cancer	0.000196	0.00114	CbGbCtD
Docetaxel—ABCB1—Vincristine—kidney cancer	0.000193	0.00112	CbGbCtD
Docetaxel—CYP3A4—urine—kidney cancer	0.000192	0.0212	CbGeAlD
Docetaxel—MAP2—cortex of kidney—kidney cancer	0.000179	0.0197	CbGeAlD
Docetaxel—MAP2—gonad—kidney cancer	0.00017	0.0188	CbGeAlD
Docetaxel—MAP2—cardiac atrium—kidney cancer	0.00017	0.0187	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000166	0.0183	CbGeAlD
Docetaxel—SLC22A7—renal system—kidney cancer	0.000164	0.0181	CbGeAlD
Docetaxel—ABCB1—Sunitinib—kidney cancer	0.000161	0.000934	CbGbCtD
Docetaxel—SLC22A7—kidney—kidney cancer	0.000159	0.0175	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vincristine—kidney cancer	0.000157	0.325	CbGdCrCtD
Docetaxel—TUBB2B—nephron tubule—kidney cancer	0.000156	0.0172	CbGeAlD
Docetaxel—SLC22A7—cortex of kidney—kidney cancer	0.000154	0.017	CbGeAlD
Docetaxel—TUBB—nephron tubule—kidney cancer	0.000148	0.0163	CbGeAlD
Docetaxel—TUBB2A—nephron tubule—kidney cancer	0.000147	0.0162	CbGeAlD
Docetaxel—TUBB4A—renal system—kidney cancer	0.000147	0.0162	CbGeAlD
Docetaxel—CYP3A4—Erlotinib—kidney cancer	0.000146	0.00085	CbGbCtD
Docetaxel—TUBB6—nephron tubule—kidney cancer	0.000145	0.016	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000142	0.0157	CbGeAlD
Docetaxel—TUBB4A—kidney—kidney cancer	0.000142	0.0156	CbGeAlD
Docetaxel—TUBB2B—renal system—kidney cancer	0.000142	0.0156	CbGeAlD
Docetaxel—CYP3A4—Paclitaxel—kidney cancer	0.000134	0.000778	CbGbCtD
Docetaxel—TUBB2B—cortex of kidney—kidney cancer	0.000133	0.0147	CbGeAlD
Docetaxel—TUBB6—renal system—kidney cancer	0.000132	0.0145	CbGeAlD
Docetaxel—TUBB4A—gonad—kidney cancer	0.000132	0.0145	CbGeAlD
Docetaxel—KIF11—Cytarabine—Gemcitabine—kidney cancer	0.000128	0.266	CbGdCrCtD
Docetaxel—TUBB6—kidney—kidney cancer	0.000127	0.014	CbGeAlD
Docetaxel—TUBB2B—gonad—kidney cancer	0.000127	0.014	CbGeAlD
Docetaxel—TUBB2B—cardiac atrium—kidney cancer	0.000127	0.014	CbGeAlD
Docetaxel—TUBB—cortex of kidney—kidney cancer	0.000126	0.0139	CbGeAlD
Docetaxel—TUBB4B—nephron tubule—kidney cancer	0.000126	0.0139	CbGeAlD
Docetaxel—TUBB2A—cortex of kidney—kidney cancer	0.000126	0.0138	CbGeAlD
Docetaxel—TUBB6—cortex of kidney—kidney cancer	0.000124	0.0137	CbGeAlD
Docetaxel—ABCB1—Doxorubicin—kidney cancer	0.000121	0.000699	CbGbCtD
Docetaxel—TUBB—cardiac atrium—kidney cancer	0.00012	0.0132	CbGeAlD
Docetaxel—TUBB2A—cardiac atrium—kidney cancer	0.000119	0.0132	CbGeAlD
Docetaxel—CYP3A4—Sorafenib—kidney cancer	0.000119	0.000691	CbGbCtD
Docetaxel—TUBB6—gonad—kidney cancer	0.000118	0.013	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—kidney cancer	0.000118	0.013	CbGeAlD
Docetaxel—CYP3A4—Vinblastine—kidney cancer	0.000118	0.000682	CbGbCtD
Docetaxel—CYP3A4—Vincristine—kidney cancer	0.000116	0.000671	CbGbCtD
Docetaxel—ABCC10—renal system—kidney cancer	0.000115	0.0127	CbGeAlD
Docetaxel—TUBB4B—renal system—kidney cancer	0.000114	0.0126	CbGeAlD
Docetaxel—TUBB6—Zalcitabine—Gemcitabine—kidney cancer	0.000114	0.237	CbGdCrCtD
Docetaxel—ABCC10—kidney—kidney cancer	0.000111	0.0123	CbGeAlD
Docetaxel—TUBB4B—kidney—kidney cancer	0.000111	0.0122	CbGeAlD
Docetaxel—ABCC10—cortex of kidney—kidney cancer	0.000108	0.012	CbGeAlD
Docetaxel—TUBB4B—cortex of kidney—kidney cancer	0.000108	0.0119	CbGeAlD
Docetaxel—ABCC10—gonad—kidney cancer	0.000103	0.0114	CbGeAlD
Docetaxel—ABCC10—cardiac atrium—kidney cancer	0.000103	0.0114	CbGeAlD
Docetaxel—TUBB4B—gonad—kidney cancer	0.000103	0.0113	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—kidney cancer	0.000102	0.0113	CbGeAlD
Docetaxel—ABCC2—nephron tubule—kidney cancer	0.000102	0.0112	CbGeAlD
Docetaxel—CYP1B1—nephron tubule—kidney cancer	9.97e-05	0.011	CbGeAlD
Docetaxel—CYP3A4—Sunitinib—kidney cancer	9.64e-05	0.00056	CbGbCtD
Docetaxel—ABCC2—renal system—kidney cancer	9.25e-05	0.0102	CbGeAlD
Docetaxel—CYP1B1—renal system—kidney cancer	9.06e-05	0.00999	CbGeAlD
Docetaxel—ABCC2—kidney—kidney cancer	8.94e-05	0.00986	CbGeAlD
Docetaxel—CYP1B1—kidney—kidney cancer	8.76e-05	0.00965	CbGeAlD
Docetaxel—ABCC2—cortex of kidney—kidney cancer	8.71e-05	0.0096	CbGeAlD
Docetaxel—CYP1B1—cortex of kidney—kidney cancer	8.53e-05	0.0094	CbGeAlD
Docetaxel—CYP1B1—gonad—kidney cancer	8.12e-05	0.00896	CbGeAlD
Docetaxel—ABCC1—cortex of kidney—kidney cancer	7.67e-05	0.00846	CbGeAlD
Docetaxel—ABCG2—nephron tubule—kidney cancer	7.42e-05	0.00818	CbGeAlD
Docetaxel—ABCC1—cardiac atrium—kidney cancer	7.3e-05	0.00804	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—kidney cancer	7.22e-05	0.000419	CbGbCtD
Docetaxel—CYP3A5—nephron tubule—kidney cancer	6.89e-05	0.00759	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—kidney cancer	6.26e-05	0.553	CrCbGaD
Docetaxel—CYP3A5—renal system—kidney cancer	6.26e-05	0.0069	CbGeAlD
Docetaxel—CYP3A5—kidney—kidney cancer	6.05e-05	0.00667	CbGeAlD
Docetaxel—CYP3A5—cortex of kidney—kidney cancer	5.9e-05	0.0065	CbGeAlD
Docetaxel—TUBB—Azacitidine—Gemcitabine—kidney cancer	5.82e-05	0.121	CbGdCrCtD
Docetaxel—Paclitaxel—ABCB1—kidney cancer	5.06e-05	0.447	CrCbGaD
Docetaxel—CYP3A4—renal system—kidney cancer	4.7e-05	0.00518	CbGeAlD
Docetaxel—CYP3A4—kidney—kidney cancer	4.54e-05	0.00501	CbGeAlD
Docetaxel—ABCB1—nephron tubule—kidney cancer	3.66e-05	0.00403	CbGeAlD
Docetaxel—ABCB1—renal system—kidney cancer	3.33e-05	0.00367	CbGeAlD
Docetaxel—ABCB1—kidney—kidney cancer	3.22e-05	0.00354	CbGeAlD
Docetaxel—ABCB1—cortex of kidney—kidney cancer	3.13e-05	0.00345	CbGeAlD
Docetaxel—ABCB1—gonad—kidney cancer	2.98e-05	0.00329	CbGeAlD
Docetaxel—TUBB6—Azacitidine—Gemcitabine—kidney cancer	2.4e-05	0.0499	CbGdCrCtD
Docetaxel—Immune system disorder—Capecitabine—kidney cancer	7.29e-06	0.000175	CcSEcCtD
Docetaxel—Chest pain—Paclitaxel—kidney cancer	7.29e-06	0.000175	CcSEcCtD
Docetaxel—Arthralgia—Paclitaxel—kidney cancer	7.29e-06	0.000175	CcSEcCtD
Docetaxel—Myalgia—Paclitaxel—kidney cancer	7.29e-06	0.000175	CcSEcCtD
Docetaxel—Mediastinal disorder—Capecitabine—kidney cancer	7.27e-06	0.000175	CcSEcCtD
Docetaxel—Decreased appetite—Gemcitabine—kidney cancer	7.25e-06	0.000174	CcSEcCtD
Docetaxel—Hypersensitivity—Dactinomycin—kidney cancer	7.25e-06	0.000174	CcSEcCtD
Docetaxel—Chills—Capecitabine—kidney cancer	7.24e-06	0.000174	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7.24e-06	0.000174	CcSEcCtD
Docetaxel—Arrhythmia—Capecitabine—kidney cancer	7.21e-06	0.000173	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.2e-06	0.000173	CcSEcCtD
Docetaxel—Fatigue—Gemcitabine—kidney cancer	7.19e-06	0.000173	CcSEcCtD
Docetaxel—Gastrointestinal pain—Vincristine—kidney cancer	7.19e-06	0.000173	CcSEcCtD
Docetaxel—Dizziness—Sorafenib—kidney cancer	7.15e-06	0.000172	CcSEcCtD
Docetaxel—Pain—Gemcitabine—kidney cancer	7.13e-06	0.000172	CcSEcCtD
Docetaxel—Constipation—Gemcitabine—kidney cancer	7.13e-06	0.000172	CcSEcCtD
Docetaxel—Nausea—Erlotinib—kidney cancer	7.13e-06	0.000172	CcSEcCtD
Docetaxel—Alopecia—Capecitabine—kidney cancer	7.13e-06	0.000171	CcSEcCtD
Docetaxel—Dry mouth—Paclitaxel—kidney cancer	7.13e-06	0.000171	CcSEcCtD
Docetaxel—Diarrhoea—Sunitinib—kidney cancer	7.11e-06	0.000171	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—kidney cancer	7.07e-06	0.00017	CcSEcCtD
Docetaxel—Mental disorder—Capecitabine—kidney cancer	7.07e-06	0.00017	CcSEcCtD
Docetaxel—Asthenia—Dactinomycin—kidney cancer	7.06e-06	0.00017	CcSEcCtD
Docetaxel—Confusional state—Paclitaxel—kidney cancer	7.04e-06	0.000169	CcSEcCtD
Docetaxel—Malnutrition—Capecitabine—kidney cancer	7.02e-06	0.000169	CcSEcCtD
Docetaxel—Erythema—Capecitabine—kidney cancer	7.02e-06	0.000169	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—kidney cancer	6.99e-06	0.000168	CcSEcCtD
Docetaxel—Anaphylactic shock—Paclitaxel—kidney cancer	6.98e-06	0.000168	CcSEcCtD
Docetaxel—Oedema—Paclitaxel—kidney cancer	6.98e-06	0.000168	CcSEcCtD
Docetaxel—Abdominal pain—Vincristine—kidney cancer	6.95e-06	0.000167	CcSEcCtD
Docetaxel—Body temperature increased—Vincristine—kidney cancer	6.95e-06	0.000167	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—kidney cancer	6.94e-06	0.000167	CcSEcCtD
Docetaxel—Infection—Paclitaxel—kidney cancer	6.94e-06	0.000167	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—kidney cancer	6.89e-06	0.000166	CcSEcCtD
Docetaxel—Dysgeusia—Capecitabine—kidney cancer	6.88e-06	0.000165	CcSEcCtD
Docetaxel—Dizziness—Sunitinib—kidney cancer	6.88e-06	0.000165	CcSEcCtD
Docetaxel—Feeling abnormal—Gemcitabine—kidney cancer	6.87e-06	0.000165	CcSEcCtD
Docetaxel—Shock—Paclitaxel—kidney cancer	6.87e-06	0.000165	CcSEcCtD
Docetaxel—Vomiting—Sorafenib—kidney cancer	6.87e-06	0.000165	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—kidney cancer	6.87e-06	0.000165	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—kidney cancer	6.87e-06	0.000165	CcSEcCtD
Docetaxel—Nervous system disorder—Paclitaxel—kidney cancer	6.85e-06	0.000165	CcSEcCtD
Docetaxel—Thrombocytopenia—Paclitaxel—kidney cancer	6.84e-06	0.000164	CcSEcCtD
Docetaxel—Tachycardia—Paclitaxel—kidney cancer	6.82e-06	0.000164	CcSEcCtD
Docetaxel—Rash—Sorafenib—kidney cancer	6.81e-06	0.000164	CcSEcCtD
Docetaxel—Dermatitis—Sorafenib—kidney cancer	6.81e-06	0.000164	CcSEcCtD
Docetaxel—Back pain—Capecitabine—kidney cancer	6.79e-06	0.000163	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—kidney cancer	6.79e-06	0.000163	CcSEcCtD
Docetaxel—Skin disorder—Paclitaxel—kidney cancer	6.78e-06	0.000163	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.77e-06	0.000163	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.77e-06	0.000163	CcSEcCtD
Docetaxel—Headache—Sorafenib—kidney cancer	6.77e-06	0.000163	CcSEcCtD
Docetaxel—Muscle spasms—Capecitabine—kidney cancer	6.75e-06	0.000162	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—kidney cancer	6.73e-06	0.000162	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—kidney cancer	6.72e-06	0.000162	CcSEcCtD
Docetaxel—Anorexia—Paclitaxel—kidney cancer	6.66e-06	0.00016	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.63e-06	0.000159	CcSEcCtD
Docetaxel—Vomiting—Sunitinib—kidney cancer	6.61e-06	0.000159	CcSEcCtD
Docetaxel—Body temperature increased—Gemcitabine—kidney cancer	6.59e-06	0.000159	CcSEcCtD
Docetaxel—Rash—Sunitinib—kidney cancer	6.56e-06	0.000158	CcSEcCtD
Docetaxel—Dermatitis—Sunitinib—kidney cancer	6.55e-06	0.000158	CcSEcCtD
Docetaxel—Hypotension—Paclitaxel—kidney cancer	6.53e-06	0.000157	CcSEcCtD
Docetaxel—Headache—Sunitinib—kidney cancer	6.51e-06	0.000157	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—kidney cancer	6.5e-06	0.000156	CcSEcCtD
Docetaxel—Anaemia—Capecitabine—kidney cancer	6.49e-06	0.000156	CcSEcCtD
Docetaxel—Hypersensitivity—Vincristine—kidney cancer	6.48e-06	0.000156	CcSEcCtD
Docetaxel—Nausea—Sorafenib—kidney cancer	6.42e-06	0.000154	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.36e-06	0.000153	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—kidney cancer	6.33e-06	0.000152	CcSEcCtD
Docetaxel—Insomnia—Paclitaxel—kidney cancer	6.32e-06	0.000152	CcSEcCtD
Docetaxel—Asthenia—Vincristine—kidney cancer	6.31e-06	0.000152	CcSEcCtD
Docetaxel—Syncope—Capecitabine—kidney cancer	6.3e-06	0.000151	CcSEcCtD
Docetaxel—Leukopenia—Capecitabine—kidney cancer	6.29e-06	0.000151	CcSEcCtD
Docetaxel—Paraesthesia—Paclitaxel—kidney cancer	6.27e-06	0.000151	CcSEcCtD
Docetaxel—Vomiting—Dactinomycin—kidney cancer	6.26e-06	0.000151	CcSEcCtD
Docetaxel—Dyspnoea—Paclitaxel—kidney cancer	6.23e-06	0.00015	CcSEcCtD
Docetaxel—Somnolence—Paclitaxel—kidney cancer	6.21e-06	0.000149	CcSEcCtD
Docetaxel—Palpitations—Capecitabine—kidney cancer	6.21e-06	0.000149	CcSEcCtD
Docetaxel—Rash—Dactinomycin—kidney cancer	6.21e-06	0.000149	CcSEcCtD
Docetaxel—Nausea—Sunitinib—kidney cancer	6.18e-06	0.000149	CcSEcCtD
Docetaxel—Loss of consciousness—Capecitabine—kidney cancer	6.17e-06	0.000148	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—kidney cancer	6.17e-06	0.000148	CcSEcCtD
Docetaxel—Dyspepsia—Paclitaxel—kidney cancer	6.15e-06	0.000148	CcSEcCtD
Docetaxel—Cough—Capecitabine—kidney cancer	6.13e-06	0.000147	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—kidney cancer	6.08e-06	0.000146	CcSEcCtD
Docetaxel—Decreased appetite—Paclitaxel—kidney cancer	6.07e-06	0.000146	CcSEcCtD
Docetaxel—Hypertension—Capecitabine—kidney cancer	6.06e-06	0.000146	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.03e-06	0.000145	CcSEcCtD
Docetaxel—Fatigue—Paclitaxel—kidney cancer	6.02e-06	0.000145	CcSEcCtD
Docetaxel—Diarrhoea—Vincristine—kidney cancer	6.02e-06	0.000145	CcSEcCtD
Docetaxel—Asthenia—Gemcitabine—kidney cancer	5.99e-06	0.000144	CcSEcCtD
Docetaxel—Myalgia—Capecitabine—kidney cancer	5.98e-06	0.000144	CcSEcCtD
Docetaxel—Arthralgia—Capecitabine—kidney cancer	5.98e-06	0.000144	CcSEcCtD
Docetaxel—Chest pain—Capecitabine—kidney cancer	5.98e-06	0.000144	CcSEcCtD
Docetaxel—Pain—Paclitaxel—kidney cancer	5.97e-06	0.000144	CcSEcCtD
Docetaxel—Constipation—Paclitaxel—kidney cancer	5.97e-06	0.000144	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.94e-06	0.000143	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—kidney cancer	5.91e-06	0.000142	CcSEcCtD
Docetaxel—Pruritus—Gemcitabine—kidney cancer	5.9e-06	0.000142	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—kidney cancer	5.88e-06	0.000141	CcSEcCtD
Docetaxel—Dry mouth—Capecitabine—kidney cancer	5.85e-06	0.000141	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—kidney cancer	5.85e-06	0.000141	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—kidney cancer	5.83e-06	0.00014	CcSEcCtD
Docetaxel—Dizziness—Vincristine—kidney cancer	5.82e-06	0.00014	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—kidney cancer	5.79e-06	0.000139	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—kidney cancer	5.79e-06	0.000139	CcSEcCtD
Docetaxel—Confusional state—Capecitabine—kidney cancer	5.78e-06	0.000139	CcSEcCtD
Docetaxel—Feeling abnormal—Paclitaxel—kidney cancer	5.76e-06	0.000138	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.74e-06	0.000138	CcSEcCtD
Docetaxel—Oedema—Capecitabine—kidney cancer	5.73e-06	0.000138	CcSEcCtD
Docetaxel—Gastrointestinal pain—Paclitaxel—kidney cancer	5.71e-06	0.000137	CcSEcCtD
Docetaxel—Diarrhoea—Gemcitabine—kidney cancer	5.71e-06	0.000137	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—kidney cancer	5.69e-06	0.000137	CcSEcCtD
Docetaxel—Infection—Capecitabine—kidney cancer	5.69e-06	0.000137	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—kidney cancer	5.68e-06	0.000137	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—kidney cancer	5.65e-06	0.000136	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—kidney cancer	5.65e-06	0.000136	CcSEcCtD
Docetaxel—Shock—Capecitabine—kidney cancer	5.64e-06	0.000136	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—kidney cancer	5.63e-06	0.000135	CcSEcCtD
Docetaxel—Nervous system disorder—Capecitabine—kidney cancer	5.62e-06	0.000135	CcSEcCtD
Docetaxel—Thrombocytopenia—Capecitabine—kidney cancer	5.61e-06	0.000135	CcSEcCtD
Docetaxel—Tachycardia—Capecitabine—kidney cancer	5.59e-06	0.000135	CcSEcCtD
Docetaxel—Vomiting—Vincristine—kidney cancer	5.59e-06	0.000134	CcSEcCtD
Docetaxel—Skin disorder—Capecitabine—kidney cancer	5.57e-06	0.000134	CcSEcCtD
Docetaxel—Rash—Vincristine—kidney cancer	5.54e-06	0.000133	CcSEcCtD
Docetaxel—Dermatitis—Vincristine—kidney cancer	5.54e-06	0.000133	CcSEcCtD
Docetaxel—Abdominal pain—Paclitaxel—kidney cancer	5.52e-06	0.000133	CcSEcCtD
Docetaxel—Body temperature increased—Paclitaxel—kidney cancer	5.52e-06	0.000133	CcSEcCtD
Docetaxel—Headache—Vincristine—kidney cancer	5.51e-06	0.000133	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—kidney cancer	5.48e-06	0.000132	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—kidney cancer	5.46e-06	0.000131	CcSEcCtD
Docetaxel—Anorexia—Capecitabine—kidney cancer	5.46e-06	0.000131	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—kidney cancer	5.41e-06	0.00013	CcSEcCtD
Docetaxel—Hypotension—Capecitabine—kidney cancer	5.36e-06	0.000129	CcSEcCtD
Docetaxel—Vomiting—Gemcitabine—kidney cancer	5.3e-06	0.000128	CcSEcCtD
Docetaxel—Rash—Gemcitabine—kidney cancer	5.26e-06	0.000127	CcSEcCtD
Docetaxel—Dermatitis—Gemcitabine—kidney cancer	5.26e-06	0.000126	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—kidney cancer	5.23e-06	0.000126	CcSEcCtD
Docetaxel—Headache—Gemcitabine—kidney cancer	5.23e-06	0.000126	CcSEcCtD
Docetaxel—Nausea—Vincristine—kidney cancer	5.22e-06	0.000126	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.22e-06	0.000126	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—kidney cancer	5.21e-06	0.000125	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—kidney cancer	5.2e-06	0.000125	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—kidney cancer	5.2e-06	0.000125	CcSEcCtD
Docetaxel—Insomnia—Capecitabine—kidney cancer	5.18e-06	0.000125	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—kidney cancer	5.17e-06	0.000124	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—kidney cancer	5.16e-06	0.000124	CcSEcCtD
Docetaxel—Paraesthesia—Capecitabine—kidney cancer	5.15e-06	0.000124	CcSEcCtD
Docetaxel—Hypersensitivity—Paclitaxel—kidney cancer	5.15e-06	0.000124	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—kidney cancer	5.14e-06	0.000124	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—kidney cancer	5.12e-06	0.000123	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—kidney cancer	5.11e-06	0.000123	CcSEcCtD
Docetaxel—Dyspnoea—Capecitabine—kidney cancer	5.11e-06	0.000123	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—kidney cancer	5.1e-06	0.000123	CcSEcCtD
Docetaxel—Dyspepsia—Capecitabine—kidney cancer	5.05e-06	0.000121	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—kidney cancer	5.01e-06	0.000121	CcSEcCtD
Docetaxel—Asthenia—Paclitaxel—kidney cancer	5.01e-06	0.000121	CcSEcCtD
Docetaxel—Decreased appetite—Capecitabine—kidney cancer	4.98e-06	0.00012	CcSEcCtD
Docetaxel—Nausea—Gemcitabine—kidney cancer	4.96e-06	0.000119	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Capecitabine—kidney cancer	4.95e-06	0.000119	CcSEcCtD
Docetaxel—Fatigue—Capecitabine—kidney cancer	4.94e-06	0.000119	CcSEcCtD
Docetaxel—Pruritus—Paclitaxel—kidney cancer	4.94e-06	0.000119	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—kidney cancer	4.92e-06	0.000118	CcSEcCtD
Docetaxel—Pain—Capecitabine—kidney cancer	4.9e-06	0.000118	CcSEcCtD
Docetaxel—Constipation—Capecitabine—kidney cancer	4.9e-06	0.000118	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—kidney cancer	4.86e-06	0.000117	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—kidney cancer	4.83e-06	0.000116	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—kidney cancer	4.83e-06	0.000116	CcSEcCtD
Docetaxel—Diarrhoea—Paclitaxel—kidney cancer	4.78e-06	0.000115	CcSEcCtD
Docetaxel—Feeling abnormal—Capecitabine—kidney cancer	4.72e-06	0.000114	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—kidney cancer	4.72e-06	0.000113	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—kidney cancer	4.7e-06	0.000113	CcSEcCtD
Docetaxel—Gastrointestinal pain—Capecitabine—kidney cancer	4.69e-06	0.000113	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—kidney cancer	4.69e-06	0.000113	CcSEcCtD
Docetaxel—Chills—Doxorubicin—kidney cancer	4.67e-06	0.000112	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—kidney cancer	4.65e-06	0.000112	CcSEcCtD
Docetaxel—Dizziness—Paclitaxel—kidney cancer	4.62e-06	0.000111	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—kidney cancer	4.6e-06	0.000111	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—kidney cancer	4.56e-06	0.00011	CcSEcCtD
Docetaxel—Body temperature increased—Capecitabine—kidney cancer	4.53e-06	0.000109	CcSEcCtD
Docetaxel—Abdominal pain—Capecitabine—kidney cancer	4.53e-06	0.000109	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—kidney cancer	4.53e-06	0.000109	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—kidney cancer	4.53e-06	0.000109	CcSEcCtD
Docetaxel—Vomiting—Paclitaxel—kidney cancer	4.44e-06	0.000107	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—kidney cancer	4.43e-06	0.000107	CcSEcCtD
Docetaxel—Rash—Paclitaxel—kidney cancer	4.4e-06	0.000106	CcSEcCtD
Docetaxel—Dermatitis—Paclitaxel—kidney cancer	4.4e-06	0.000106	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—kidney cancer	4.38e-06	0.000105	CcSEcCtD
Docetaxel—Headache—Paclitaxel—kidney cancer	4.38e-06	0.000105	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—kidney cancer	4.35e-06	0.000105	CcSEcCtD
Docetaxel—Hypersensitivity—Capecitabine—kidney cancer	4.22e-06	0.000102	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—kidney cancer	4.18e-06	0.000101	CcSEcCtD
Docetaxel—Nausea—Paclitaxel—kidney cancer	4.15e-06	9.98e-05	CcSEcCtD
Docetaxel—Asthenia—Capecitabine—kidney cancer	4.11e-06	9.89e-05	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—kidney cancer	4.06e-06	9.77e-05	CcSEcCtD
Docetaxel—Pruritus—Capecitabine—kidney cancer	4.06e-06	9.75e-05	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—kidney cancer	4.05e-06	9.75e-05	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—kidney cancer	4e-06	9.62e-05	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—kidney cancer	3.98e-06	9.57e-05	CcSEcCtD
Docetaxel—Cough—Doxorubicin—kidney cancer	3.95e-06	9.5e-05	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—kidney cancer	3.92e-06	9.43e-05	CcSEcCtD
Docetaxel—Diarrhoea—Capecitabine—kidney cancer	3.92e-06	9.43e-05	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—kidney cancer	3.91e-06	9.4e-05	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—kidney cancer	3.85e-06	9.27e-05	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—kidney cancer	3.85e-06	9.27e-05	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—kidney cancer	3.85e-06	9.27e-05	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.83e-06	9.21e-05	CcSEcCtD
Docetaxel—Dizziness—Capecitabine—kidney cancer	3.79e-06	9.12e-05	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—kidney cancer	3.77e-06	9.07e-05	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—kidney cancer	3.73e-06	8.96e-05	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—kidney cancer	3.69e-06	8.89e-05	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—kidney cancer	3.69e-06	8.89e-05	CcSEcCtD
Docetaxel—Infection—Doxorubicin—kidney cancer	3.67e-06	8.83e-05	CcSEcCtD
Docetaxel—Vomiting—Capecitabine—kidney cancer	3.64e-06	8.77e-05	CcSEcCtD
Docetaxel—Shock—Doxorubicin—kidney cancer	3.64e-06	8.74e-05	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—kidney cancer	3.62e-06	8.72e-05	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—kidney cancer	3.62e-06	8.7e-05	CcSEcCtD
Docetaxel—Rash—Capecitabine—kidney cancer	3.61e-06	8.69e-05	CcSEcCtD
Docetaxel—Dermatitis—Capecitabine—kidney cancer	3.61e-06	8.68e-05	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—kidney cancer	3.61e-06	8.67e-05	CcSEcCtD
Docetaxel—Headache—Capecitabine—kidney cancer	3.59e-06	8.64e-05	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—kidney cancer	3.59e-06	8.63e-05	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—kidney cancer	3.52e-06	8.47e-05	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—kidney cancer	3.45e-06	8.3e-05	CcSEcCtD
Docetaxel—Nausea—Capecitabine—kidney cancer	3.4e-06	8.19e-05	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.37e-06	8.1e-05	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—kidney cancer	3.34e-06	8.04e-05	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—kidney cancer	3.32e-06	7.98e-05	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—kidney cancer	3.29e-06	7.92e-05	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—kidney cancer	3.28e-06	7.9e-05	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—kidney cancer	3.25e-06	7.82e-05	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—kidney cancer	3.21e-06	7.73e-05	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.19e-06	7.67e-05	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—kidney cancer	3.19e-06	7.66e-05	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—kidney cancer	3.16e-06	7.6e-05	CcSEcCtD
Docetaxel—Pain—Doxorubicin—kidney cancer	3.16e-06	7.6e-05	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—kidney cancer	3.04e-06	7.32e-05	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—kidney cancer	3.02e-06	7.27e-05	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—kidney cancer	2.92e-06	7.03e-05	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—kidney cancer	2.92e-06	7.03e-05	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—kidney cancer	2.72e-06	6.55e-05	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—kidney cancer	2.65e-06	6.38e-05	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—kidney cancer	2.61e-06	6.29e-05	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—kidney cancer	2.53e-06	6.08e-05	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—kidney cancer	2.44e-06	5.88e-05	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—kidney cancer	2.35e-06	5.65e-05	CcSEcCtD
Docetaxel—Rash—Doxorubicin—kidney cancer	2.33e-06	5.6e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—kidney cancer	2.33e-06	5.6e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—kidney cancer	2.31e-06	5.57e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—kidney cancer	2.19e-06	5.28e-05	CcSEcCtD
Docetaxel—BCL2—Immune System—ERBB2—kidney cancer	1.06e-06	5.05e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC5A5—kidney cancer	1.06e-06	5.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—kidney cancer	1.06e-06	5.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN2B—kidney cancer	1.06e-06	5.04e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.05e-06	5.01e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MTOR—kidney cancer	1.04e-06	4.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RAF1—kidney cancer	1.04e-06	4.98e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—kidney cancer	1.04e-06	4.97e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CRABP1—kidney cancer	1.04e-06	4.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RELA—kidney cancer	1.04e-06	4.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—kidney cancer	1.03e-06	4.92e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC2A1—kidney cancer	1.02e-06	4.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MTOR—kidney cancer	1.02e-06	4.86e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CCBL1—kidney cancer	1.02e-06	4.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—kidney cancer	1.02e-06	4.85e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.01e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSC1—kidney cancer	1.01e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PSMD7—kidney cancer	1.01e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ANXA1—kidney cancer	1.01e-06	4.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.01e-06	4.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDKN1B—kidney cancer	9.95e-07	4.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.83e-07	4.69e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.8e-07	4.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FLT1—kidney cancer	9.8e-07	4.68e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDKN1B—kidney cancer	9.8e-07	4.68e-05	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	9.74e-07	4.65e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTP1—kidney cancer	9.69e-07	4.62e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ITPR2—kidney cancer	9.66e-07	4.61e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—kidney cancer	9.59e-07	4.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	9.56e-07	4.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDKN1B—kidney cancer	9.55e-07	4.56e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.5e-07	4.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—JUN—kidney cancer	9.47e-07	4.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—kidney cancer	9.4e-07	4.49e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTP1—kidney cancer	9.37e-07	4.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—kidney cancer	9.37e-07	4.47e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—JUN—kidney cancer	9.33e-07	4.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	9.3e-07	4.44e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—kidney cancer	9.26e-07	4.42e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CA9—kidney cancer	9.22e-07	4.4e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—kidney cancer	9.17e-07	4.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—kidney cancer	9.16e-07	4.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TSC2—kidney cancer	9.12e-07	4.35e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	9.1e-07	4.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PAK1—kidney cancer	9.09e-07	4.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUNB—kidney cancer	9.09e-07	4.34e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—kidney cancer	9.02e-07	4.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HIF1A—kidney cancer	8.96e-07	4.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TSC2—kidney cancer	8.94e-07	4.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GSTM1—kidney cancer	8.9e-07	4.25e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—kidney cancer	8.9e-07	4.25e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—kidney cancer	8.87e-07	4.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK3—kidney cancer	8.86e-07	4.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPAT—kidney cancer	8.82e-07	4.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.82e-07	4.21e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTT1—kidney cancer	8.81e-07	4.21e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ACHE—kidney cancer	8.81e-07	4.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—kidney cancer	8.79e-07	4.2e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GSTM1—kidney cancer	8.61e-07	4.11e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.6e-07	4.1e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTP1—kidney cancer	8.52e-07	4.07e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTP1—kidney cancer	8.45e-07	4.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HIF1A—kidney cancer	8.44e-07	4.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP1A1—kidney cancer	8.44e-07	4.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK1—kidney cancer	8.43e-07	4.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TSC2—kidney cancer	8.42e-07	4.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—kidney cancer	8.39e-07	4.01e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SCARB1—kidney cancer	8.34e-07	3.98e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS1—kidney cancer	8.26e-07	3.94e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FH—kidney cancer	8.2e-07	3.91e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APRT—kidney cancer	8.2e-07	3.91e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP1A1—kidney cancer	8.16e-07	3.9e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PSMD7—kidney cancer	8.1e-07	3.86e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—kidney cancer	8.07e-07	3.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KIT—kidney cancer	8.06e-07	3.85e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—kidney cancer	8e-07	3.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—kidney cancer	7.96e-07	3.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.9e-07	3.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—kidney cancer	7.89e-07	3.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KIT—kidney cancer	7.89e-07	3.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CRABP1—kidney cancer	7.84e-07	3.74e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—kidney cancer	7.83e-07	3.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK3—kidney cancer	7.83e-07	3.74e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—kidney cancer	7.76e-07	3.71e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK3—kidney cancer	7.71e-07	3.68e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPC3—kidney cancer	7.71e-07	3.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BCHE—kidney cancer	7.67e-07	3.66e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.64e-07	3.65e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC5A5—kidney cancer	7.58e-07	3.62e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA2—kidney cancer	7.5e-07	3.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK1—kidney cancer	7.45e-07	3.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KIT—kidney cancer	7.44e-07	3.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—kidney cancer	7.44e-07	3.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF2—kidney cancer	7.43e-07	3.55e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP1A1—kidney cancer	7.42e-07	3.54e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—kidney cancer	7.42e-07	3.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—kidney cancer	7.41e-07	3.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN2B—kidney cancer	7.4e-07	3.53e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP1A1—kidney cancer	7.36e-07	3.51e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK1—kidney cancer	7.34e-07	3.5e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A1—kidney cancer	7.32e-07	3.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALAD—kidney cancer	7.31e-07	3.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ITPR2—kidney cancer	7.29e-07	3.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1R—kidney cancer	7.18e-07	3.43e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.13e-07	3.4e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—kidney cancer	7.1e-07	3.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—kidney cancer	7.03e-07	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—kidney cancer	6.99e-07	3.34e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.97e-07	3.33e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.93e-07	3.31e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—kidney cancer	6.93e-07	3.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RAF1—kidney cancer	6.92e-07	3.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—kidney cancer	6.75e-07	3.22e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.7e-07	3.2e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.68e-07	3.19e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PGK1—kidney cancer	6.68e-07	3.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ACHE—kidney cancer	6.65e-07	3.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTT1—kidney cancer	6.65e-07	3.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LDHB—kidney cancer	6.55e-07	3.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—kidney cancer	6.46e-07	3.08e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—kidney cancer	6.37e-07	3.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RAF1—kidney cancer	6.32e-07	3.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RELA—kidney cancer	6.29e-07	3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SCARB1—kidney cancer	6.29e-07	3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—kidney cancer	6.29e-07	3e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—kidney cancer	6.26e-07	2.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS1—kidney cancer	6.23e-07	2.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—kidney cancer	6.2e-07	2.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—kidney cancer	6.2e-07	2.96e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAF1—kidney cancer	6.19e-07	2.96e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—kidney cancer	6.19e-07	2.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—kidney cancer	6.17e-07	2.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—kidney cancer	6.16e-07	2.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—kidney cancer	6.13e-07	2.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMD7—kidney cancer	6.11e-07	2.92e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTP1—kidney cancer	6.11e-07	2.91e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—kidney cancer	6.08e-07	2.9e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—kidney cancer	6.05e-07	2.89e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—kidney cancer	6.04e-07	2.88e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—kidney cancer	5.99e-07	2.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—kidney cancer	5.91e-07	2.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSC2—kidney cancer	5.9e-07	2.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAF1—kidney cancer	5.84e-07	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—kidney cancer	5.79e-07	2.77e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BCHE—kidney cancer	5.79e-07	2.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—kidney cancer	5.78e-07	2.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—kidney cancer	5.78e-07	2.76e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—kidney cancer	5.72e-07	2.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—kidney cancer	5.7e-07	2.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—kidney cancer	5.69e-07	2.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA9—kidney cancer	5.68e-07	2.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—kidney cancer	5.67e-07	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—kidney cancer	5.67e-07	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—kidney cancer	5.65e-07	2.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—kidney cancer	5.65e-07	2.7e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—kidney cancer	5.61e-07	2.68e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—kidney cancer	5.54e-07	2.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A1—kidney cancer	5.52e-07	2.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JUN—kidney cancer	5.51e-07	2.63e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—kidney cancer	5.49e-07	2.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—kidney cancer	5.47e-07	2.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—kidney cancer	5.36e-07	2.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—kidney cancer	5.35e-07	2.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—kidney cancer	5.33e-07	2.55e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.32e-07	2.54e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.27e-07	2.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—kidney cancer	5.23e-07	2.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—kidney cancer	5.21e-07	2.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KIT—kidney cancer	5.21e-07	2.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—kidney cancer	5.05e-07	2.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—kidney cancer	5.02e-07	2.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—kidney cancer	4.99e-07	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—kidney cancer	4.96e-07	2.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—kidney cancer	4.92e-07	2.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—kidney cancer	4.9e-07	2.34e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—kidney cancer	4.85e-07	2.32e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CRABP1—kidney cancer	4.83e-07	2.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—kidney cancer	4.75e-07	2.27e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTP1—kidney cancer	4.61e-07	2.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—kidney cancer	4.56e-07	2.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ITPR2—kidney cancer	4.49e-07	2.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—kidney cancer	4.48e-07	2.14e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—kidney cancer	4.46e-07	2.13e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—kidney cancer	4.42e-07	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—kidney cancer	4.38e-07	2.09e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—kidney cancer	4.38e-07	2.09e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—kidney cancer	4.37e-07	2.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—kidney cancer	4.34e-07	2.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—kidney cancer	4.34e-07	2.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—kidney cancer	4.25e-07	2.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—kidney cancer	4.23e-07	2.02e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—kidney cancer	4.23e-07	2.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—kidney cancer	4.21e-07	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—kidney cancer	4.12e-07	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—kidney cancer	4.1e-07	1.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTT1—kidney cancer	4.1e-07	1.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ACHE—kidney cancer	4.1e-07	1.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—kidney cancer	4.09e-07	1.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAF1—kidney cancer	4.09e-07	1.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RELA—kidney cancer	4.07e-07	1.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—kidney cancer	4.04e-07	1.93e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A1—kidney cancer	4.01e-07	1.92e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—kidney cancer	4.01e-07	1.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—kidney cancer	4e-07	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—kidney cancer	3.99e-07	1.91e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—kidney cancer	3.97e-07	1.89e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SCARB1—kidney cancer	3.88e-07	1.85e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—kidney cancer	3.85e-07	1.84e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS1—kidney cancer	3.84e-07	1.83e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—kidney cancer	3.82e-07	1.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—kidney cancer	3.78e-07	1.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMD7—kidney cancer	3.76e-07	1.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—kidney cancer	3.76e-07	1.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—kidney cancer	3.75e-07	1.79e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—kidney cancer	3.69e-07	1.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—kidney cancer	3.67e-07	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—kidney cancer	3.57e-07	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BCHE—kidney cancer	3.57e-07	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JUN—kidney cancer	3.57e-07	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—kidney cancer	3.54e-07	1.69e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.52e-07	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—kidney cancer	3.47e-07	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—kidney cancer	3.45e-07	1.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.4e-07	1.62e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—kidney cancer	3.16e-07	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—kidney cancer	3.12e-07	1.49e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—kidney cancer	3.09e-07	1.47e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—kidney cancer	2.99e-07	1.43e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—kidney cancer	2.99e-07	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—kidney cancer	2.95e-07	1.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—kidney cancer	2.87e-07	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTP1—kidney cancer	2.84e-07	1.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—kidney cancer	2.8e-07	1.34e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—kidney cancer	2.76e-07	1.32e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—kidney cancer	2.72e-07	1.3e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.69e-07	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—kidney cancer	2.69e-07	1.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—kidney cancer	2.65e-07	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—kidney cancer	2.61e-07	1.25e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.47e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—kidney cancer	2.43e-07	1.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—kidney cancer	2.39e-07	1.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—kidney cancer	2.35e-07	1.12e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—kidney cancer	2.08e-07	9.94e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.95e-07	9.29e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—kidney cancer	1.84e-07	8.8e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—kidney cancer	1.47e-07	7.02e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—kidney cancer	1.47e-07	7.01e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—kidney cancer	1.28e-07	6.12e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.05e-08	4.32e-06	CbGpPWpGaD
